metabolic

A unique collection of 1283 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.

A unique collection of 683 diabetes related compounds;

A unique collection of 2247 anti-obesity compounds for high throughput and high content screening;

A unique collection of 614 gut microbial metabolites which can be used for HTS and HCS;

A collection of 499 selected human endogenous metabolites for high throughput and high content screening.

A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;

A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2720 kinase inhibitors regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

791 peptides can be used in peptide drug development and signaling transduction and mechanism study;

A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;

702 glycometabolism-related comounds, can be used for HTS and HCT;

80 species of cyclic peptide molecules for high-throughput and high-content screening;

A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;

A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;

A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);

80 well-chosen unique AMPK-targeted small molecules；

A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);

A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);

678 hypertension-related small molecules for high-throughput and high-content screening.

A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa

A unique collection of 420 natural flavor small molecules.